Femasys (FEMY) Cash from Investing Activities Growth (1y) (2021 - 2026)
Femasys (FEMY) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -528.34% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -4.51% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -4.35% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -82.56% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 40.11% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -13.64% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -420.31% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -104.07% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | 18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.08% |
| Dec 31, 2025 | -77.84% |
| Sep 30, 2025 | 45.50% |
| Jun 30, 2025 | 53.15% |
| Mar 31, 2025 | -7.15% |
| Dec 31, 2024 | -146.36% |
| Sep 30, 2024 | -1,519.60% |
| Jun 30, 2024 | -228.78% |
| Mar 31, 2024 | -912.92% |
| Dec 31, 2023 | 52.17% |
| Sep 30, 2023 | -46.54% |
| Jun 30, 2023 | 63.97% |
| Mar 31, 2023 | 92.61% |
| Dec 31, 2022 | 20.86% |
| Sep 30, 2022 | 89.45% |
| Jun 30, 2022 | -1,296.18% |
| Dec 31, 2021 | -703.19% |
| Sep 30, 2021 | -653.54% |